Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin and Beta Blocker in Decompensated Cirrhosis
NCT06764966Phase 2Recruiting
- Sponsor
- CAMC Health System
- Start
- Sep 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in decompensated cirrhosis, sponsored by CAMC Health System. Started Sep 2025; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT06764966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06764966.